Effects of Maraviroc and Efavirenz on Markers of Immune Activation and Inflammation and Associations with CD4⁺ Cell Rises in HIV-Infected Patients

• Nicholas Funderburg,

  Affiliation Case Western Reserve University, Cleveland, Ohio, United States of America

  ⨯
• Magdalena Kalinowska,

  Affiliation Case Western Reserve University, Cleveland, Ohio, United States of America

  ⨯
• James Eason,

  Affiliation Case Western Reserve University, Cleveland, Ohio, United States of America

  ⨯
• James Goodrich,

  Affiliation ViiV Healthcare, Research Triangle Park, North Carolina, United States of America

  ⨯
• Jayvant Heera,

  Affiliation Pfizer Global Research and Development, New London, Connecticut, United States of America

  ⨯
• Howard Mayer,

  Affiliation EMD Serono, Rockland, Massachusetts, United States of America

  ⨯
• Natasa Rajicic,

  Affiliation Pfizer Inc, New York, New York, United States of America

  ⨯
• Hernan Valdez ,

  * E-mail: hernan.valdez@pfizer.com

  Affiliation Pfizer Inc, New York, New York, United States of America

  ⨯
• Michael M. Lederman

  Affiliation Case Western Reserve University, Cleveland, Ohio, United States of America

  ⨯